AbbVie Inc. the Spinoff for 2013
AbbVie Inc (ABBV) just started trading in 2013. AbbVie is the first 'Spinoff' for Wall Street in the New Year and has separated from Abbott Labs (ABT).
AbbVie was the pharmaceutical division of Abbott Labs, so far its bounced from $34 to $35 per share. This spinoff has been in motion since 2011. Before the deal, Abbott was one of the largest healthcare companies in the world. The aging world population is going to keep popping pills made by AbbVie including the anti-inflammation drug Humira, the popular painkiller Vicodin, and cholesterol drug Niaspan.
Abbott's chairman and CEO Miles White called the event "the most transformative action" in the company's 125-history. AbbVie CEO Richard Gonzalez said that with his company's existing assets and focus on innovation "we intend to create significant value for our shareholders."
Bottom line: Time will tell if this spinoff will be successful and Wells Fargo is the first to set a price target of $33 to $34. For now add this stock to your watch list and as more information becomes available place your trading accordingly. To review the company check out their website at www.abbvie.com/
Best of the Blogs
Scanning and identifying the best blog entries every hour
- What Happens After A Crash? | ZeroHedge
- September Macro Update: Majority of Data Still Positive | Financial Sense
- Saudi Arabia Just Cut Crude Selling Prices To The US, Europe And Asia | ZeroHedge
- Market Recap Sep 4, 2015 | FundMyMutualFund
- Martin Armstrong "Astonished" At Hillary Email Scandal | ZeroHedge
- Lessons From a Failed Prediction | Financial Sense
- China and Global Market Turbulence | Financial Sense
The most relevant financial news and articles from the Internets
- Google's Nexus 6 is the cheapest it's ever been... | Business Insider
- Here's how the US depends on China | Business Insider
- UN climate talks plagued by twin fears | Business Insider
- America's murder problem could be solved by this brilliant new insight | Business Insider
- Canada less welcoming to refugees under Harper's... | Business Insider
- ESPN pulls Schilling for next month after anti-Muslim... | Business Insider
- Futures are lower after the jobs report (SPY, DJI, IXIC) | Business Insider